February 22, 2019
The Ministry of Health, Labor and Welfare (MHLW) on February 21 approved label expansions for a throng of drugs including AbbVie’s Humira (adalimumab) for the treatment of hidradenitis suppurativa. Humira is now the first drug in Japan to carry the...read more